Clinical trial

Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia

NCT00872326

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-12-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2007-12-01Date precision: month

Registry last updated2014-11-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Peripheral Vascular Diseasesunresolved

Diabetic Footunresolved

Interventions

Autologous Bone Marrow Mononuclear CellsPROCEDURE

Sponsors & collaborators

Andalusian Network for Design and Translation of Advanced Therapieslead sponsor

Carlos III Health Institutecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00872326 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.